Zoetis

Update in progress

ZTS (NYSE)

Company RatingNeutral
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic

Zoetis discovers, develops, manufactures and sells medicines, vaccines, diagnostics, biodevices and genetic tests for animal health worldwide. It serves companion animals (dogs, cats, horses) and livestock (cattle, swine, poultry, fish, sheep), offering parasiticides, dermatology, anti-infectives, pain management, and precision health solutions. It provides point-of-care tests, instruments, reagents, lab services, nutritionals, and other non‑drug products. Clients are veterinarians, producers and pet owners. Headquartered in Parsippany, NJ.

Company score

Sentiment: -0.09; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.06; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.21; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: -0.58; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: -0.04; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: -0.06; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive